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Abstract
One of many important features of the tumour microenvironment is
that it is a place of active Darwinian selection where different tumour
clones become adapted to the variety of ecological niches that make up
the microenvironment. These evolutionary processes turn the microenvi-
ronment into a powerful source of tumour heterogeneity and contribute
to the development of drug resistance in cancer. Here, we describe a
computational tool to study the ecology of the microenvironment and re-
port results about the ecology of the tumour microenvironment and its
evolutionary dynamics.
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Introduction
The tumour microenvironment is characterized by large chemical gradients and
contains a mixture of normal and tumour cells. The presence of high gradi-
ents favours the formation of different ecological niches which can become an
important source of tumour heterogeneity [1, 25, 4, 39, 3, 13].
The actual size of the niches is quite small, as it is mostly determined by
the structure of the scaffold of capillary vessels that envelope and feed the
tumour mass. This structure is highly irregular, with a chaotic blood vessel
network, a missing lymphatic network, elevated acidity, poor oxygenation, and
high interstitial fluid pressure. The distance between blood vessels may be as
large as a few hundred µm, and the regions in between them can become highly
hypoxic [39].
The fine-graininess and the large spatial variability are essential features in
the formation of the ecological niches and they must belong to any mathemati-
cal model that aims to explain tumour heterogeneity as the result of Darwinian
selection driven by the local environment. The importance of the microenvi-
ronment is widely recognized, and several researchers have tackled the problem
of its description and understanding from the computational point of view, e.g.
[24, 28, 15, 37, 30, 40, 41] , and the reviews [21, 10].
The studies, however, mainly focus on the biochemical, cellular and bio-
physical properties of the tumour microenvironment and not on its active role
in providing varied evolutionary paths to genetic variants of the tumour cells.
As it has already been pointed out [14, 12], the adaptive evolution of tumour
clones (central concept of Darwinian dynamics) is driven by the formation of
new environmental niches. Many practical difficulties limit the experimental
study of the adaptation process, while computer simulations can shed light —
albeit in a limited way — on the dynamics of many steps like the convergent
evolution of different genotypes to the same phenotype, and the selective loss of
specific cell functions.
Simulations of avascular solid tumours show that the microenvironment of these
small cell aggregates is formed by rather homogeneous niches with smooth gra-
dients of oxygen, of other nutrients, waste molecules and cell viability [18].
After the angiogenic transition, however, the microenvironment differentiates
in unpredictable ways. To identify underlying processes and provide reason-
ing, we have developed a computational model that is a tool to understand the
fine-grained features of a simplified tumour microenvironment, i.e. of a microen-
vironment that contains only tumour cells and blood vessels. This is a rather
strong simplifying assumption, since experimental observations show that in ad-
dition to tumour cells the microenvironment contains several other important
cell types such as stromal and immune cells. We wish to stress that this as-
sumption is a necessary compromise, because no computer model can presently
describe the huge biological complexity of the tumour microenvironment and
capture its growth at appropriate spatial and temporal resolutions.
Our computational model combines two different simulation programs, namely,
a lattice-free simulation of small avascular solid tumours and a lattice-based sim-
ulation of the blood vessels dynamics in solid tumours. As we discuss below,
both models have been individually validated with experimental data, and here
we provide a first validation of the combined model by correctly reproducing
the relevant observed gradients of tumour oxygenation and other biochemical
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Figure 1: Distribution of cell phases in a tumour spheroid (avascular in vitro
tumour) simulated with VBL. The figure shows a clipped spheroid, to display
the cell phases in the inside of the spheroid. The colors represent different cell
phases, and in this example it is only important to note that the necrotic regions
are red. Note that there is no clear cut boundary between the proliferating
part of the necrotic core. The triangulation used by VBL is also shown. This
simulated tumour spheroid comprises almost 24000 cells.
and biological features. Next, we use the combined model to explore how the
tumour microenvironment takes shape in small solid tumours at the transition
from the avascular to the vascular growth phases, the so-called angiogenic switch
[5]. We follow the complex dynamics of this process in detail and in real time
and show that, already at these early stages of tumour development, the diver-
sity of environmental niches is high enough to promote adaptive evolution of
tumour variants.
Brief outline of “Virtual Biology Lab” (VBL) and
Tumorcode
In this section we give a short description of the two programs that have been
merged. The present account is very brief as both programs have been described
in detail in past papers (for VBL, see [18, 7, 8, 20, 26], for Tumorcode, see
[22, 11, 33]).
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VBL
VBL is a lattice-free, cell-based program that can simulate both: the growth
and proliferation of disperse cells and of more complex, avascular cell clusters
(tumour spheroids). It contains a detailed simulation of the metabolic activity
of each cell including discrete events at the individual cell level (for instance:
mitochondrial partitioning at mitosis), and has the potential to activate pheno-
typic differentiation. More specifically, the model has the following features:
• The model of human tumor cells includes both- the internal biochemical
processes and a phenomenological description of the biomechanics of cells.
• Spatially, each cell is a two-compartment structure, the inside of the cell
and the adjacent extracellular environment or intercellular space; this is
important to handle simple diffusion and facilitated diffusion across the
cell membrane at the same time.
• Discrete events are simulated and interleaved between successive deter-
ministic steps; the random nature of some of them contributes to the
stochasticity of the simulation as a whole.
• Each cell is characterized by its own phenotype which means that a specific
set of parameters is linked to an individual cell.
• Enzyme activity is modulated both by pO2 concentration and by pH.
• Weighting of molecular paths and cellular mechanisms is possible.
• The program simulates dispersed tumor cells and cell clusters (tumor
spheroids) including the intercellular space.
• The surrounding environment is an integral part of the simulation.
The numerical methods used in VBL have been described elsewhere [6],
here we only mention that although the simulation is lattice-free, continuum
processes are actually discretized on the continually-variable irregular lattice
defined by the Delaunay triangulation [9] based on the cells’ centres which also
defines the proximity relations among cells that are necessary to compute the
cell-cell forces. We find that the computational geometry library CGAL (https:
//www.cgal.org) [29] is an easy tool that offers necessary triangulation features
amended by the possibility to calculate alpha shapes. This is necessary to define
the surface or contact zone of the spheroid with the environment. It is important
to note that the simulation spans many orders of magnitude in time which makes
the large system of differential equations describing the deterministic part of the
program extremely stiff. Therefore we solve the equations by means of implicit
integration methods, that allow for comparatively large time steps (of the order
of 1-10 s in terms of simulated time) [19].
Figure 1 shows an example of a tumour spheroid simulated by VBL. As we
have shown in the past, the main metabolic, morphologic and kinetic parameters
are correctly reproduced both for isolated cells and for cells grown as three-
dimensional clusters [6, 8].
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Figure 2: 500 µm thick slice trough tumour vasculature of 1cm lateral size.
For 3D illustration we extent vessels with radius bigger than 20 µm for another
750 µm above and below the slice. According to the lower panels: arteries are
displayed in varying reddish color and veins in varying blueish color (unit is also
µm). Capillaries and young vessel are shown in green.
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Tumorcode
While cell-cell interactions like in VBL naturally produce nearly spherical struc-
tures, modelling the growth of blood vessels moves the complexity of the simu-
lation one step higher to the level of tissue morphogenesis. The list of models is
long. For an appropriate discussion of the existing models for tumor vasculature
see [23].
Solid tumours grow in originally healthy tissue featuring a normal vascula-
ture build up by a hierarchically organized arterio-venous blood vessel network
that is then dynamically modified by the growing tumor. An integrative model-
ing approach thus has to address two issues: first, it has to find an appropriate
representation of the original vasculature of the host tissue; and second, the
dynamics of the given blood vessel network has to be defined, which includes
the insertion of new vessels via angiogenesis as well as the removal of exist-
ing vessels (old and new) via vessel regression, and the modification of existing
vessels via dilation, constriction or occlusion. Moreover, the network carries a
blood flow and transports and emits oxygen, nutrients and drugs, which has to
be represented, too. Various modeling approaches have been presented in the
past ( for a review see e.g. [23, 36, 22] ), here we use the simulation framework
Tumorcode described in [11], which does not only create artificial arterio-venous
blood vessel networks representing the healthy initial vasculature, but includes
vascular remodeling during solid tumour growth by angiogenesis, vessel dilation,
regression and collapse. The created networks were tested against experimen-
tal data and successfully reproduced: 1) morphology and flow characteristics
[31, 32], 2) interstitial fluid flow and pressure [35], and 3) tissue oxygenation
[33] for both, healthy and tumour tissue.
Again, here is a short list of its main features of Tumorcode:
• Hemodynamics includes the phase separation effect (Fåhræus-Lindqvist
effect) and different rheologies.
• Concentrations in the surrounding environment are computed according to
a continuum model, i.e., according to a set of partial differential equations
discretized by finite elements method solved with the Trilinos C++ library
(https://trilinos.org) [17].
• Angiogenesis, i.e., the addition of new segments, is driven by the VGEF
gradient and is partly stochastic [22].
• As the tumour grows, the vasculature and the blood flows change, and
the modified shear stress leads to blood vessel dilation or to blood vessel
collapse [22].
• A low local VGEF growth factor concentration produces blood vessel re-
gression [22].
• The program computes the interaction with surrounding tissues to com-
pute the extraction of oxygen and nutrients from blood vessels.
• The program returns blood flow, oxygen concentration, metabolite con-
centration, etc, in blood vessels and surrounding tissues.
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• The blood vessel hematocrit acts as source for oxygen dissolved in tissue
and the tissue simultaneously consumes the oxygen. In [34] we explain
how the coupled set of non linear differential equations is solved to obtain
the oxygen partial pressure for each blood vessel segment.
Figure 2 shows an example of a tumour vasculature simulated by Tumor-
code. You can clearly distinguish the vasculature inside the tumour from the
surrounding healthy tissue. Note the difference in length scale when comparing
Figure 2 and Figure 1, and the fact that the tumour is a continuous structure
( governed by reaction-diffusion equations [11]) in Tumorcode. In contrast to
VBL, it cannot describe the evolutionary features of the microenvironment at
the single cell level.
The merging of the two programs
Initialize artificial vasculature with Tumorcode
Seed single VBL cell amid vasculature and 
initialize single cell variables
End condition reached?
(Either tumour diameter equals 66% 
of the simulation box’s z-extension or 
the maximum time is reached) 
YES
Stop
Run VBL for 1 h of simulated time with 50 s
timesteps
NO
Interpolate tumour volume and oxygen
consumption from VBL tumour cell cluster
Remodel vasculature
Recalculate oxygen content in vasculature
Figure 3: Flowchart of combined VBL
and Tumorcode simulation
To merge the two programs into one,
we had to match the spatial struc-
tures of the two programs. The cells
are not confined to a lattice however
the diffusion processes in VBL are cal-
culated by means of a disordered De-
launay triangulation which is not per-
manent and has a variable size, as
cells position change at each time step
while the cells grow and proliferate.
The situation is almost the reverse
in Tumorcode where blood vessel seg-
ments belong to an FCC lattice and
the continous space is discretized by
a cubic lattice to solve the partial dif-
ferential equations. We interpolated
cell properties from the cells position
to the surrounding nodes of the cubic
lattice (compare Figure 3). In partic-
ular, the Tumorcode requires an oxy-
gen consumption field and each cell
is considered as point- like source of
growth factor. Once the growth fac-
tor field exceeds the threshold, the
vessel remodelling of Tumorcode starts.
We estimate that the accurate calculation of any substance concentration for
a given cell requires O(NCNBV) number of operations, where NC is the num-
ber of cells and NBV is the number of blood vessels segments. Since both NC
and NBV easily exceed 106 in the smallest-sized biologically relevant simulation
runs, O(NCNBV) ∼ 1012 per time step, making the simulations utterly unman-
ageable. To reduce the computational complexity, we take into account that
only the nearest blood vessels actually contribute to the inputs and outputs of
the different molecules in the vicinity of a given cell trimming the large num-
ber of cell-blood vessel pairs to O(NC). Moreover, the timesteps to follow cell
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Figure 4: Artificial blood vessel network containing a tumour after 23 simulated
days past the initial seeding. For visualization we removed a quarter of the
system. The color code in the bottom left corresponds to the blood pressure at
a given vessel segment. Cells are colored by their cell phase. Red: phases G1m
and G1p; yellow: phases S, G2 and M; light green: dead cells
biochemistry are of order 1-10 s while biological relevant timesteps for vascular
remodelling are in the order of hours. Therefore we introduce two different time
steps to avoid a huge number of useless sweeps over the blood vessel network
(compare Figure 3).
Development of the microenvironment in small solid
tumours
With the program described before, we studied selected aspects of the tumour
microenvironment. To this end, we carried out simulation runs with three dif-
ferent tumour seeds: 1. at the center of a blood vessel network, 2. close to an
arterial bifurcation, 3. close to a venous bifurcation. The details of each simu-
lation are reported in the supplemental material. Here we display the results in
a way that allows an easy comparison with measurements [38, 16].
As expected, the seeding is important in the very first steps of tumour
growth: a seed close to blood vessels leads to fast growth and to a quick re-
modelling of the blood vessel network; for seeds far from blood vessels, the
initial growth is slower and the subsequent initial development of the tumor
microenvironment differs slightly.
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Seed at the center of a blood vessel network
The computational approach provides an easy access to information that is hard
to obtain with experiments and allows multiple ways of visualization (compare
Figure 4). Here we take advantage of the information about the distance to the
nearest blood vessel for every cell. We start with the distribution which is a
defining feature of the microenvironment, as larger distances mean less oxygen
and nutrients, and therefore starvation and death for many tumour cells. In
Figure 5 we see how the distribution changes while the tumour grows. The
distribution at the early stage ( 280 hours past seeding) ranges from 0 to 80 µm
ensuring a optimal oxygenation to all cells and gets distorted until it covers a
range of up to 160 µm at a later stage ( 580 hours past seeding) where cells no
receive a sufficient input of oxygen and nutrients.
Intuitively the increase in the mean of cell-blood vessel distances leads to a
decrease of available oxygen and nutrients, and to an increase of lactate ions
and to a lower pH. Since the cell-blood vessel distance is known, we can display
space-time data on the distributions of cell radii, pO2 and pH (Figure 6) - the
data confirms the intuition. We uploaded two videos where we visualize pO2
(fredrich:po2:2018) and pH (fredrich:pH:2018) during the the complete of
the growth processes.
Finally, the changes in the microenvironment stretch the cell proliferation
period and therefore modifies the cell cycle distribution as seen in Figure 7
where we can follow the formation of a necrotic core. At the beginning (280
hours past initial seed) the relative amount of cells in the different phases varies
with the distance from the nearest vessel. Surprisingly this relative amount
stays almost constant after the establishment of different niches. Compare with
Figure 4 were we show the cell phase distribution in a more pictorial way. Even
in such a small tumour we observe the initial development of necrotic regions
which characterizes the development of the tumour microenvironment.
Actual tumours have irregular shapes, while the cells in VBL are not polar-
ized, and when grown in uniform environments produce nearly spherical shapes.
In the presented case the blood vessel network drives the growth in specific di-
rections and we expect a marked deviation from sphericity already with small
simulated tumours. Ideally, in a spherical tumour all cells on the surface have
the same distance to the centroid. We find that the distribution of distances
from the spheroid’s surface to the centroid a) broadens and b) deviates from
symmetric form as the tumour grows which is a clear indication of the deforma-
tion of the cell cluster and of its deviation from sphericity.
Seed close to an arterial or venous bifurcation
Helminger et al. [16] measured the partial oxygen pressure and pH within
different tumours. To compare our simulations with their experimental results,
we seeded the initial tumour cell close to bifurcations, both arterial and venous,
and sampled the cells along different lines (for details see supplemental material).
Figure 9 is meant to illustrates the sampling procedure while we show data for
a early and a late simulation state in Figure 10.
It is interesting to note that the left panel in first row in Figure 10 shows a dip
in both pO2 and pH approximately midway between the two blood vessels. The
right panel in the same row, taken at a later time, shows a maximum at roughly
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Figure 5: Empirical distribution of the distance to the closest vessel for all
cells in the developing tumour. The snapshots are taken at simulated times 280
hours, 380 hours, 480 hours and 580 hours past the initial seed. Colors represent
the different simulation times.
the same position because a new blood vessel sprouted into the intervening
space. A detailed view of this dynamic change is shown in Figure 11, where
the mean of the pO2 data is plotted for all intermediate time points as the new
blood vessel grows.
Conclusions
As explained in the Introduction, the study of the ecology of the tumour mi-
croenvironment at the angiogenic switch is the primary motivation for the work
described in this paper and for the development of the presented complex soft-
ware tool. Indeed, the Figures 10 and 11 display a surprisingly large spatial and
temporal variability already in a very small vascularized tumour. In particular,
Figure 11 shows a continually changing and rugged landscape: this means that
the niche diversity is large, and consequently that there is a high evolutionary
pressure, and a high probability that the microenvironment selects different tu-
mour clones even in small tumours. This is important in view of the long time
required for tumour growth, as it has been estimated that a tumour requires
about 10 years to reach a size of 1 cm [27]. According to the clonal selec-
tion hypothesis new and aggressive tumour clones develop through Darwinian
selection during this extended growth time [27, 2]. The results discussed in
this paper lend further credibility to the clonal selection hypothesis, and in our
future studies we plan to demonstrate the spatial and temporal variations of
different clone populations in this very complex tumour microenvironment. In
order to highlight common and diverse evolutionary pathways in different can-
cers, we also plan to explore the adaptive evolution of cell clones in different
microenvironments mimicking different organs or tissue types to reproduce the
distinguishing features of selected tumour types.
Finally, we note that the molecular mechanisms that promote genotypic
changes in tumour clones are well known and understood, but genotypic vari-
ability is only one feature of cancer’s evolutionary landscape. The other impor-
tant feature is the variability of the environment that supervenes the genome
and drives evolution itself, and with our computational tool we can start to
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Figure 6: Sampled cell quantities vs. the distance to the nearest vessel. Top
panel: cell radius, center panel: partial oxygen pressure, bottom panel: extra-
cellular pH. Each box plot has been obtained using the values in cells at a given
distance from the nearest vessel as indicated by the abscissa. As usual, the ver-
tical error bars (“whiskers”) represent the lower and upper quartile. The data is
sampled 280, 380, 480 and 580 hours past the initial seeding. For better clarity,
we omit the complete boxes for the time points 280, 380 and 480 and plot only
the mean value in different colors.
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Figure 7: Distribution of the cell phases at different distances from the closest
blood vessel. From top row to bottom row the data is take after 280, 380, 480,
580 hours past this inital seed. The left panels show the number of cells in the
corresponding phase relative to the total number of current cells. G1m and G1p
in red, S in yellow, G2 and M in green and dead cells in black. In the right
panels we consider only alive cells. The abscissa is the distance to the nearest
vessel.
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Figure 8: Distribution of distance from tumour centroid to cells in contact with
the environment (normal tissue). The colors indicate the different sampling
times past the inital seeding. The bin size is 30 µm.
Figure 9: Sampling the partial oxygen pressure pO2 along lines between blood
vessels. We sampled along the line joining two blood vessels (bright green). Inset
A) shows the simulation state 350 hours past initial seeding; the main image
shows the state after 527 hours. Note the additional vessel due to angiogenessis.
The scale marked “pressure_at_node” refers to the pO2 value at vessel nodes
in mmHg. The scale marked “o2” referes to the value of pO2 inside cells. See
also supplemental material for more information.
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Figure 10: Data for the three measured lines. Each row corresponds to one spe-
cific line. The left column represents data taken at 350 hours of simulated time,
and the right column at 495 hours past the initial tumour seeding. Each panel
shows the sampled partial oxygen pressure (pO2) in black (left hand y-axis)
and the pH in blue (right hand y-axis). To improve visibility, the data points
of pO2 and pH are shifted against each other by 2 µm. Each line was sampled
by 30 points within a sphere of radius 10 µm. The vertical lines represent the
standard deviation.
14
distance along line/ m
0 25 50 75 100 125 150 175 ho
urs
 aft
er s
eed
360
380
400
420
440
460480
500
pO
2/m
m
H
g
14
16
18
20
22
24
Figure 11: Change of pO2 due to the blood vessel dynamics. This data ex-
tends those in the first row of Figure 10. In contrast to Figure 10, we show all
intermediate time points in this plot.
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explore its Darwinian dynamics [14].
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